Food supplement firms looking to make a splash and grab consumers' attention with thought-provoking marketing campaigns push the boundaries to stand out from the crowd. But marketers must always remain mindful of overstepping regulatory red lines. Unfortunately for Italy’s Sofar SPA, simply posing a question in an advertisement for its Cistiflux cranberry supplement was a step too far and landed the firm in hot water with the local regulator.
A print ad published in the Italian press for Cistiflux A plus 36+D (type-A proanthocyanidins from American cranberry extract and D-mannose) contained the question: “Urinary tract infection
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?